NDC 65862-036 – Lamivudine and Zidovudine

Lamivudine 150 mg/1; Zidovudine 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC65862-036

Product details

Brand name
Lamivudine and Zidovudine
Generic name
Lamivudine and Zidovudine
Labeler
Aurobindo Pharma Limited
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA077558
Marketed since
May 5, 2017
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for LAMIVUDINE and ZIDOVUDINE →

Package NDC codes (2)

Package NDCDescriptionSince
65862-036-106 BLISTER PACK in 1 CARTON (65862-036-10) / 10 TABLET, FILM COATED in 1 BLISTER PACKMay 5, 2017
65862-036-6060 TABLET, FILM COATED in 1 BOTTLE (65862-036-60)May 5, 2017

Other LAMIVUDINE and ZIDOVUDINE products